Company
Vetoquinol SA
Headquarters: Lure, France
Employees: 2,525
CEO: Mr. Matthieu Frechin
Market Cap
€1.06 Billion
EUR as of July 1, 2023
US$1.15 Billion
France
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
Zoetis Inc.
|
$78.54 B |
MERCK Kommanditgesellschaft auf Aktien
|
$70.69 B |
Takeda Pharmaceutical Company Limited
|
$46.59 B |
Haleon plc
|
$37.99 B |
|
Eisai Co. Ltd
|
$17.26 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
|
UnitedHealth Group
|
$428.70 B |
|
Lilly
|
$417.05 B |
|
Johnson & Johnson
|
$412.24 B |
Novo Nordisk
|
$329.83 B |
|
Merck
|
$275.82 B |
Detailed Description
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of pain management, anti-infective, cardiology-nephrology, care and hygiene, antiparasiticides, behavior, internal medicine, and reproduction for cats, dogs, cattle, and pigs. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
Unlock the Power of Financial AI:
Try Disfold AI Free for 7 Days!
Stocks & Indices
Vetoquinol SA has the following listings and related stock indices.
Stock: Euronext: VETO wb_incandescent
Stock: FSX: 8JM wb_incandescent